The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2019
Filed:
Oct. 08, 2013
Applicant:
Ascendis Pharma Ophthalmology Division A/s, Hellerup, DK;
Inventors:
Harald Rau, Dossenheim, DE;
Thomas Knappe, Heidelberg, DE;
Burkhardt Laufer, Dossenheim, DE;
Romy Reimann, Heidelberg, DE;
Samuel Weisbrod, Heidelberg, DE;
Kennett Sprogøe, Palo Alto, CA (US);
Nicola Bisek, Heidelberg, DE;
Sebastian Stark, Heidelberg, DE;
Tobias Voigt, Bensheim, DE;
Assignee:
Ascendis Pharma Opthalmology Division A/S, Hellerup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 9/00 (2006.01); A61K 39/44 (2006.01); A61K 45/06 (2006.01); A61K 47/60 (2017.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 9/0048 (2013.01); A61K 39/44 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); A61K 47/6903 (2017.08); A61K 47/6921 (2017.08); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01);
Abstract
The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a VEGF neutralizing prodrug, which comprises a VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions.